Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

LTJ — Predicate Candidate Screening

34 FDA 510(k) clearances under this product code; the 50 most recent screened below.

90 daysmedian FDA review time
266 days90th percentile
34clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K251630Atellica IM Total PSA II (tPSAII)Siemens Healthcare Diagnostics, Inc.2026-01-052220
K162378FREND PSA PLUS (reagent cartridge)Nanoentek USA, Inc.2017-05-172660
K124056FREND PSA PLUS (REAGENT CARTRIDGE)Nanoentek, Inc.2013-05-291490
K031343TPSA FLEX REAGENT CARTRIDGEDade Behring, Inc.2003-05-15160
K022177PROSTATE SPECIFIC ANTIGEN (PSA) ASSAY FOR THE ADVIA INTEGRATBayer Diagnostics Corp.2002-12-171670
K022288COMPLEXED PROSTATE SPECIFIC ANTIGEN (CPSA) ASSAY FOR THE BAYBayer Corp.2002-12-171550
K010550VIDAS TOTAL PROSTATE SPECIFIC ANTIGEN (TPSA), MODEL 30 428bioMerieux, Inc.2001-04-24570
K003963DIMENSION PSA FLEX REAGENT CARTRIDGEDade Behring, Inc.2001-02-28680
K002376ADVIA: CENTAUR AND ACS: 180 CPSA ASSAYBayer Corp.2000-10-26830
K003094FASTPACK PSA IMMUNOASSAY, FASTPACK ANALYZERQualigen, Inc.2000-10-25220
K002121TOTAL PSA MICROTITER ELISAOncogene Science, Inc.2000-08-30480
K002313COMPLEXED PSA MICROTITER ELISAOncogene Science, Inc.2000-08-30300
K994419FASTPACK PSA IMMUNOASSAY, FASTPACK SYSTEMQualisys Diagnostics, Inc.2000-06-281822
K994221BAYER PSA ASSAYBayer Corp.2000-04-131200
K000566MODOFICATION TO VITRO IMMUNODIAGNOSTIC PRODUCTS PSA REAGENT Ortho-Clinical Diagnostics, Inc.2000-03-09160
K990234QUALISYS PSA IMMUNOASSAYQualisys Diagnostics, Inc.1999-07-081640
K984289VITROS IMMUNODIAGNOSTIC PRODUCTS PSA CALIBRATORS, VITROS IMMOrtho-Clinical Diagnostics, Inc.1999-03-121010
K982949ELECSYS PSA, MODEL 2010Boehringer Mannheim Corp.1998-10-27670
K982948ELECSYS PSA, MODEL # ELECSYS 1010Boehringer Mannheim Corp.1998-10-27670
K981634BIOCIRCUITS IOS PROSTATE SPECIFIC ANTIGEN (PSA) TEST CARTRIDBiocircuits Corp.1998-10-131580
K981839ACS:CENTAUR PSA2 IMMUNOASSAYChiron Diagnostics Corp.1998-08-12780
K973243ACTIVE PSA ELISA (DSL-10-9700)Diagnostic Systems Laboratories, Inc.1998-08-033390
K973244ACTIVE PSA IRMA (DSL-9700)Diagnostic Systems Laboratories, Inc.1998-08-033390
K980376THE COMPLEXED PSA ASSAY FOR THE BAYER IMMUNO 1 SYSTEMBayer Corp.1998-04-23830
K974842IMMULITE 2000 3RD GENERATION PSADiagnostic Products Corp.1998-04-211180
K980716ADVANTAGE CHEMILUMINESCENCE PROSTATE SPECIFIC ANTIGEN (PSA) Nichols Institute Diagnostics1998-04-03860
K974816ACCESS(R) PSA REAGENTS ON THE ACCESS(R) IMMUNOASSAY ANALYZERBeckman Instruments, Inc.1998-02-20590
K974189ELECSYS PSA (ON ELECSYS 1010)Boehringer Mannheim Corp.1998-01-06600
K972021IMMULITE THIRD GENERATION PSA (LKUPI,LKUP5)Diagnostic Products Corp.1997-10-311510
K973101PROSTATE SPECIFIC ANTIGEN METHODDade Chemistry Systems, Inc.1997-09-18300
K972095IMMULITE 2000 PSADiagnostic Products Corp.1997-08-22790
K964351ELECSYS PSA ASSAYBoehringer Mannheim Corp.1997-07-252660
K964595OPUS PSA TEST SYSTEMBehring Diagnostics, Inc.1997-06-242180
K965085ENZYMUN-TEST PSABoehringer Mannheim Corp.1997-03-19900

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda